Cabasa Alduz, Pochettino Alberto
Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Ann Cardiothorac Surg. 2016 Jul;5(4):296-309. doi: 10.21037/acs.2016.06.01.
Type A aortic dissection (TAAD) is a complex cardiovascular disease that is associated with high perioperative morbidity and mortality. The most effective approach is still being debated-such as the best cannulation technique, and conservative versus extensive initial surgery. We reviewed our experience over the last 20 years and examined for variables that correlated with observed outcomes.
All patients who underwent TAAD repair were reviewed. Chi-Square tests, Fisher Exact tests and Wilcoxon tests were performed where appropriate. Survival and freedom from reoperations were analyzed with the Kaplan-Meier actuarial method.
Acute TAAD was associated with a higher incidence of permanent stroke (P=0.010), renal failure (P=0.025), prolonged mechanical ventilator support (P=0.004), higher operative mortality (P=0.039) and higher 30-day mortality (P=0.003) compared to chronic TAAD. There was a trend towards higher risk for transient neurologic events among patients who were reoperated on (P=0.057). Extensive proximal repair led to longer perfusion and cross clamp times (P<0.001) and the need for temporary mechanical support post-operatively (P=0.011). More patients that had extensive distal repair underwent circulatory arrest (P=0.009) with no significant differences in the incidence of peri-operative complications, early, middle and long-term survival compared to the conservative management group. Overall survival in our series was 66.73% and 46.30% at 5 and 10 years respectively (median survival time: 9.38 years). There was a significant improvement in operative mortality (P=0.002) and 30-day mortality (P=0.033) in the second decade of our study.
TAAD is a complex disease with several options for its surgical management. Each technique has its own advantages and complications and surgical management should be individualized depending on the clinical presentation. We propose our present approach to maximize benefits in both the short and long term.
A型主动脉夹层(TAAD)是一种复杂的心血管疾病,围手术期发病率和死亡率较高。最有效的治疗方法仍存在争议,如最佳插管技术,以及保守治疗与广泛的初始手术治疗。我们回顾了过去20年的经验,并研究了与观察到的结果相关的变量。
对所有接受TAAD修复的患者进行回顾。在适当情况下进行卡方检验、Fisher精确检验和Wilcoxon检验。采用Kaplan-Meier精算方法分析生存率和再次手术的无复发生存率。
与慢性TAAD相比,急性TAAD的永久性卒中发生率(P=0.010)、肾衰竭发生率(P=0.025)、机械通气支持时间延长(P=0.004)、手术死亡率较高(P=0.039)和30天死亡率较高(P=0.003)。再次手术的患者发生短暂性神经事件的风险有升高趋势(P=0.057)。广泛的近端修复导致灌注和阻断时间延长(P<0.001),术后需要临时机械支持(P=0.011)。与保守治疗组相比,更多接受广泛远端修复的患者接受了循环阻断(P=0.009),围手术期并发症发生率、早期、中期和长期生存率无显著差异。我们系列研究的5年和10年总生存率分别为66.73%和46.30%(中位生存时间:9.38年)。在我们研究的第二个十年中,手术死亡率(P=0.002)和30天死亡率(P=0.033)有显著改善。
TAAD是一种复杂的疾病,其手术治疗有多种选择。每种技术都有其自身的优点和并发症,手术治疗应根据临床表现个体化。我们提出了目前的治疗方法,以在短期和长期内实现最大效益。